相关实验视频

Updated: Sep 12, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

在切除胰腺癌患者中,P53功能状态与整体存活率相关

Hui Chen¹, Alisha Agarwal¹, Sreekanth Yellanki¹

¹Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Journal of surgical oncology

|August 7, 2025

概括

胰腺癌患者没有获得功能的P53突变的生存时间较短. 了解P53突变亚型对于预测胰腺管道腺癌 (PDAC) 的结果至关重要.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
癌症研究癌症研究

背景情况:

在胰腺管腺癌 (PDAC) 中,P53基因经常发生突变.
P53的正常功能对于DNA修复,复制和亡至关重要.
P53中的突变在PDAC中很常见,影响瘤抑制功能.

研究的目的:

在切除的PDAC中研究不同P53突变亚型的预后意义.
为了确定P53突变状态是否会影响胰腺癌患者的存活率.

主要方法:

对330名切除PDAC的患者进行了回顾性队列研究 (2016-2022年).
下一代测序 (NGS) 用于分析P53瘤基因型.
将P53突变分为野生型 (WT),功能增益型 (GOF) 和非GOF亚型.

主要成果:

在74%的PDAC患者中发现了P53突变.
与WT (32.2个月) 和GOF (36.2个月) 相比,非GOF P53突变与总生存时间 (25.6个月) 显著缩短.
非GOF突变也与减少无病生存时间 (14.6个月) 与WT (19.6个月) 和GOF (18.3个月) 相比相关.

结论:

根据功能状态分类的P53突变亚型在PDAC中具有差异性预后价值.
研究结果表明,P53突变分析可以帮助预测胰腺癌患者的生存率和复发率.
需要进一步的研究来验证这些P53突变的预后影响.

关键词:

在P53中,P53是P53 我们的PDAC是PDAC.功能获取 - 功能获取.癌症结局的结果.胰腺管道腺癌瘤

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...